|Articles|April 12, 2022

Robust Association Between Antibiotics and C Difficile Infection, Even in Outpatient Settings

Author(s)Nina Cosdon

The risk of a community-acquired C difficile infection was 7-fold higher for outpatients with antibiotic exposure.

Antibiotic exposure is known to raise the risk of Clostridioides difficile infection(CDI). An estimated 30% of outpatient antibiotic prescriptions may be unnecessary, raising the risk of not only C diff infections but antimicrobial resistance as well.

One study, presented at the Society for Healthcare Epidemiology of America Conference 2022 (SHEA), examined the prevalence of community-acquired Clostridioides difficile infection (CA-CDI) among persons without recent hospitalization. To assess the correlation between outpatient antibiotic exposure and risk of CA-CDI, the investigators recruited a 2-year patient cohort from Community-Based Outpatient Clinics (CBOC).

Primary care visits and non-visit antibiotic prescriptions from 2018-2019 were included in the study. Investigators categorized patient characteristics, clinical diagnoses, and antibiotics prescribed for each encounter. They estimated the unadjusted odds ratio of outpatient antibiotics for CA-CDI, and used logistic regression to adjust for additional risk factors.

The final cohort included 884787 patients with clinic visits that fulfilled study criteria. Of these participants, 3533 were prescribed antibiotics and 5 (0.14%) developed CA-CDI. Of the 81254 patients who were not prescribed antibiotics, 15 (0.02%) developed CA-CDI. After adjusting for patient age and comorbidities, the odds ratio of CA-CDI after outpatient antibiotic prescription remained statistically significant.

These findings were presented by Robin Jump, MD, PhD, who concluded that although CA-CDI episodes were infrequent, the odds of CA-CDI were 7-fold higher in outpatients with antibiotic exposure than those without. “Antibiotic stewardship interventions that emphasize adverse events as a result of care provided in the outpatient setting, rather than as events limited to acute care settings, may mitigate CDI risk,” the study authors concluded.

The study, In Veteran Outpatients, Antibiotics Remain Significant Risk Factor for Community-Acquired Clostridiodes difficile Infection,” was presented on April 12 during the Society for Healthcare Epidemiology of America Conference 2022 (SHEA).


Related to this article

IDSA/ESCMID Statement on Staphylococcus aureus: Follow-Up Blood Cultures
Staphylococcus aureus Bacteremia (SAB) causes significant morbidity and globally is the leading cause of death from bloodstream infection. This month, the IDSA and ESCMID released 7 consensus statements to assist in managing individuals with SAB. This review will focus on the adult patient population and additional information on pediatric population statements can be assessed in the guideline. Here is a closer look at Consensus Statement 2: Follow-up Blood Cultures.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.